Berislav Bošnjak Ivan Odak Christiane Ritter Klaus Stahl Theresa Graalmann Lars Steinbrück Rainer Blasczyk Christine S Falk Thomas F Schulz Hans Heinrich Wedemeyer Markus Cornberg Arnold Ganser Reinhold Förster Christian Koenecke
10.3389/fimmu.2021.721738
Front Immunol
2021 Aug 12;12:721738.
cd19 car-t cell covid – 19 nk cell sars – cov – 2 t cell convalescent plasma (cp)
CC BY
https://pubmed.ncbi.nlm.nih.gov/34456929/
B-Lymphocytes / immunology COVID-19 / immunology COVID-19 / therapy Immunologic Deficiency Syndromes / immunology Immunotherapy, Adoptive Killer Cells, Natural / immunology T-Lymphocytes / immunology
B-Lymphocytes / immunology COVID-19 / immunology COVID-19 / therapy Immunologic Deficiency Syndromes / immunology Immunotherapy, Adoptive Killer Cells, Natural / immunology T-Lymphocytes / immunology Case Reports Research Support, Non-U.S. Gov't COVID-19 / complications COVID-19 Serotherapy Female Humans Immunization, Passive Immunoglobulins, Intravenous Immunologic Deficiency Syndromes / complications Lymphocyte Activation Lymphopoiesis SARS-CoV-2 Viral Load Immunoglobulins, Intravenous
PMC8387963
34456929
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy
2021